Figure 1: Tafenoquine Succinate Structure (Image 01)
Arakoda Tablet, Film Coated
Product Images NDC 71475-257
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Arakoda (NDC 71475-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by 60 Degrees Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Company Logo (Image 02)
Sixty Degrees is a phrase or brand name that may refer to a company, product, or service. 60N Pharmaceuticals seems to be the intended company or brand name, but the scanning has an apparent typo of "Phatmacauticals". Without further information, it is difficult to determine the exact nature of either of these entities.*
Principal Display Panel (Carton Label)
Arakoda™ (Tafenoquine) is a tablet for oral use, available in the strength of 100mg. It is supplied in Unit Dose Tablets, with each packet containing 16 tabs (2x8), and is Rx only medication. The tablets come with a Medication Guide for each patient. The NDC number for the tablets is 71475-257-01, and it is important to keep it out of reach of children. The remaining text has errors and cannot be interpreted.*
Image 04
This is a medication called "Arakoda" in tablet form that contains 100mg of tafenoguine succinate. It comes with a medication guide to give to patients and should be stored at a temperature between 20°C to 25°C. It is manufactured by 60 Pharmaceuticals LLC in India. Dosage and administration information can be found in the prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
